Navigation Links
Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American Academy of Ophthalmology Meeting
Date:11/19/2013

SEATTLE, Nov. 19, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported analyses of Phase 3 clinical data showing the impact of OMS302 on reducing the incidence of miosis (pupil constriction) during intraocular lens replacement (ILR). OMS302 is the company's proprietary Pharmacosurgery® product being developed for all ILR, including cataract surgery and refractive lens exchange.

The analyses were presented by Steve Whitaker, M.D., Omeros' vice president of clinical development and chief medical officer on November 17 at the Annual American Academy of Ophthalmology (AAO) Meeting in New Orleans. The clinical data presented at the AAO meeting and shown below demonstrated that, in these clinical trials in which all patients received standard-of-care preoperative mydriatic topical drops, OMS302 reduced the occurrence of intraoperative pupil constriction. Intraoperative miosis is an important risk factor for surgical complications. As shown in the figure below, pupil constriction of at least 3 millimeters was common in control patients while constriction greater than 1 millimeter was uncommon in OMS302-treated patients.

(Photo: http://photos.prnewswire.com/prnh/20131119/MM19781 )

"We are pleased with the recognition that the recent clinical data for OMS302 received from the ophthalmic community during the AAO annual meetings," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "Ophthalmologists continue to appreciate the potential clinical benefits of OMS302, and we look forward to the drug's expected commercial launch in 2014."

About Omeros' OMS302 Program
OMS302 is Omeros' product being developed for use du
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "North American Active Wound ... Application (Surgical Wound, & Ulcer), by End-User (In-Patient, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... is estimated to grow at a CAGR of ...
(Date:5/21/2015)... Calif. , May 21, 2015  Cardica, Inc. (Nasdaq: ... new employee Greg Watson , the company,s vice president ... of the company,s common stock, at a per share exercise ... 2015. The stock option was granted pursuant to Cardica, Inc.,s ... directors in May 2015 under Rule 5653(c)(4) of the Nasdaq ...
(Date:5/21/2015)... , May 21, 2015 ... Arzneimittelfälschungen - Zwecks Leistungsvergleich zur Expertise ... auf EG-Mitgliedstaaten verwiesen, in denen uneingeschränkt ... Wählen Sie ein Aegate-Land: beispielsweise BELGIEN ... zur Bekämpfung von Arzneimittelfälschungen (FMD) handelt ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... Group today announced the availability of the DebMed®GMS™ ... monitoring system to report hand hygiene compliance rates ... now immediately monitor compliance rates based on the ... Hygiene." A stand-alone system, the DebMed®GMS™ can be ...
... 1, 2011 Pharma ChemOutsourcing today announced that it would ... USA,s various state biotechnology associations to help make the event ... the September 12-15 show in New Jersey. "We ... biotechnology companies over the past 12 years. Many of them ...
Cached Medicine Technology:Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 2Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 3Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey 2
(Date:5/22/2015)... Pioneer Millworks, the largest reclaimed wood company in ... reclaimed wood, introducing their latest reclaimed wood products at ... offerings, Vat 35, Reclaimed Teak , and Prairie ... largest design event. , “Designers, architects, builders, and homeowners ... see and feel the variety of wood surfaces in ...
(Date:5/22/2015)... NS (PRWEB) May 22, 2015 Following ... a sale agreement with US-based health brand Nature’s Way, ... Skin brand. Retention of Ascenta Skin is an integral ... is excited about this opportunity to further develop Ascenta ... , Ascenta Skin is a breakthrough, anti-aging skincare ...
(Date:5/22/2015)... DC (PRWEB) May 22, 2015 Family, ... University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. Leffall, ... , The luncheon began after Grand Rounds in the ... Leffall, waited anxiously outside the auditorium, trying to keep ... him, but if he sees me, he’ll know something ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms ... specialize in include decks, additions, kitchen remodeling, interior renovations, ... more. , The redesigned logo is a fresh ... It includes two geometrical lines that represent the engineering ... be used with many things associated with the company. ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... ... States we,re still seeing discriminatory actions towards the medicine. Former and fired ... the young age of 30 he fights Cancer and a Brain Tumor. ... using medicinal marijuana and the American Civil Liberties Union is behind him every ...
... Eating a ... lead to blindness. , ... 29, 2010 -- In some cases cataracts can lead to blindness. A study has now found ... found that reducing the levels of fatty food and salt consumed significantly protected women from the ...
... ... at bedside so staff members are drawn in to the room to interact with patients,” ... ... have a new solution for improving patient satisfaction scores. “We use a MagnaSnap to hold ...
... , ... Performance-based training programs help individuals achieve greater athletic outcomes and increase their performance. ... ... http://www.alleghenymedical.com/ ), one of Pittsburgh,s premiere health care facilities, is an organization of ...
... ... antivirus company specializing in threat prevention and cloud based antivirus solutions, announced today the ... operate cross carrier and worldwide with Google reporting 60,000 Android handsets shipped each day., ... (PRWEB) July ...
... Today, the American Academy of Otolaryngology Head ... consensus statement to address ambiguities and disparities in the ... Nasal valve compromise (NVC) is a distinct and primary ... ambiguities and disparities in the diagnosis and management of ...
Cached Medicine News:Health News:Fired Wal-Mart Employee Accepts Full Scholarship to The Medical Marijuana Academy 2Health News:Healthy Diet 'Wards off Cataracts' - Age UK 2Health News:Hospital Caregivers use MagnaSnap Paper Clamps at Bedside to Improve Patient Satisfaction Scores, 2Health News:Hospital Caregivers use MagnaSnap Paper Clamps at Bedside to Improve Patient Satisfaction Scores, 3Health News:Allegheny Medical's SportsCare Programs Combine Lifestyle, Fitness and Behavior Management with Quality Medical Treatments 2Health News:Bluepoint Security Launches World's First Cloud Antivirus For The Google Android Mobile Platform 2Health News:AAO-HNS releases consensus statement: diagnosis and management of nasal valve compromise 2
Fundamental help with all major urologic conditions and diseases, plus time-saving recommendations on important problems....
The perfect solution for quick, easy reference on the wards, on rounds, in the office, and at the bedside. See vital information on specific signs and symptoms, diagnostic tests, and the gamut of neu...
Neurology, neurosurgery, and internal medicine residents and practitioners will find this mobile solution an essential reference for their day-to-day practice....
... Cochrane Reviews enable all those involved with ... with the very latest evidence in their ... becomes harder each year as the volume ... problem by delivering the best single source ...
Medicine Products: